BUSINESSTHE RIO TIMES
Brazil’s Weight-Loss Drug Market Enters a Price War
Eli Lilly reduced the price of its weight-loss drug Mounjaro in Brazil by up to 36% through a loyalty program, with starter packs dropping from R$3,350 to R$2,250. Some drug combinations saw price cuts exceeding R$2,000, triggering a price war in Brazil's weight-loss drug market.
Related Signal
Adjacent reporting
- Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales
- Hims Sales Miss on Rising Competition for Weight-Loss Drugs
- Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
- People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says
- Novo Nordisk partners with OpenAI in weight loss drug race
- Trump unveils Regeneron deal to lower drug prices